March 23, 2016.
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should be included as one of Pharmaceutical Executive's 2016 Emerging Pharma Leaders.
As the pharma industry faces a turbulent road ahead, the patent cliff, rising world players, US healthcare reform, etc., the previous ways of doing business just won’t cut it. So who are the new leaders steering the industry through the coming challenges? Which executives are revamping the industry through pure innovation to boost pharma to new heights in the 21st century?
These emerging leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today! Deadline for submissions is May 2, 2016.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.